Invention Grant
![Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders](/docs/US/2024-02-06/US11890340B2/abs.jpg.600x600.jpg)
- Patent Title: Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
-
Application No.: US17051678Application Date: 2019-04-30
-
Publication No.: US11890340B2Publication Date: 2024-02-06
- Inventor: Michael Brian Fessler , Carmen J. Williams , Wan-Chi Lin
- Applicant: The United States of America, as Represented By the Secretary, Department of Health and Human Services
- Applicant Address: US MD Bethesda
- Assignee: The United States of America as Represented By The Secretary of the Department of Health and Human Services
- Current Assignee: The United States of America as Represented By The Secretary of the Department of Health and Human Services
- Current Assignee Address: US MD Rockville
- Agency: Sughrue Mion, PLLC
- International Application: PCT/US2019/029801 2019.04.30
- International Announcement: WO2019/213020A 2019.11.07
- Date entered country: 2020-10-29
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/713 ; A61K31/7088 ; A61P11/00 ; C07K16/28 ; C07K14/705 ; C12N15/113 ; A61K45/06 ; A61K39/00 ; G01N33/68
![Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders](/abs-image/US/2024/02/06/US11890340B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed herein are methods of treating or preventing a lung disorder comprising administering to a subject a composition comprising an agent that modulates activity and/or expression of Epithelial Membrane Protein 2 (EMP2) in an amount effective to treat or prevent the lung disorder and compositions useful in such for methods.
Public/Granted literature
- US20210309737A1 USE OF EPITHELIAL MEMBRANE PROTEIN 2 [EMP2] TARGETING AGENTS IN TREATING LUNG DISORDERS Public/Granted day:2021-10-07
Information query
